Lion Bioscience last week appointed Friedrich von Bohlen, Christoph Mutter, and Jan Traenckner to its new supervisory board. The three replace J rgen Dormann, Klaus Pohle, and Richard Roy, who resigned from the supervisory board in October. Von Bohlen, who will serve as chairman, was formerly CEO of Lion and also serves as chairman of the board of Private Life BioMed in Frankfurt, Germany, and is on the board of Oncoscore in Basel, Switzerland. Mutter is a lawyer, certified public accountant, and tax advisor, and is currently chairman of the board at Balloon of Mannheim, Germany, vice chairman of the board at Huber Portfolio of Frankfurt, Germany, and a board member at StarCapital, also based in Frankfurt. Traenckner is the founder and CEO of VentureCheck, a private equity company based in Munich, Germany.
Claire Fraser, president of the Institute for Genomic Research, and Steven Salzberg, senior bioinformatics director, at TIGR, have been named as fellows of the American Association for the Advancement of Science, TIGR said last week.